NCT05761509 "Observational Study on Tolerability and Observance of Post-exposure Prophylaxis With Doravirine in HIV Viral Risk" Status COMPLETED Phase N/A
NCT05761223 A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849 Status RECRUITING Phase PHASE1/PHASE2
NCT05756569 Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology Status RECRUITING Phase PHASE2
NCT05751187 Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05746208 Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors Status RECRUITING Phase PHASE2
NCT05737199 Assessment of the Efficacy and Safety of Pembrolizumab for Ovarian Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05733715 Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma Status RECRUITING Phase EARLY_PHASE1
NCT05733286 REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant Status COMPLETED Phase PHASE2
NCT05727579 DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study Status COMPLETED Phase PHASE4
NCT05726370 Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC Status RECRUITING Phase PHASE2
NCT05722652 A Multicomponent Clinic-based Intervention to Promote COVID-19 Vaccine Intention and Uptake Among Diverse Youth and Adolescents Status COMPLETED Phase NA
NCT05722015 A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05714085 Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036) Status RECRUITING Phase PHASE2/PHASE3
NCT05711719 Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction Status COMPLETED Phase PHASE2
NCT05710224 Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002) Status COMPLETED Phase PHASE2
NCT05709860 An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy Status COMPLETED Phase NA
NCT05708950 A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) Status UNKNOWN Phase PHASE1/PHASE2